 |
My research group
at Kean University (KU) is focused on drug discovery using a multi-disciplinary
approach, particularly to enhance student learning (see: Big
Payoffs Possible for Small-Molecule Screening). Our recent therapeutic
targets have included antibiotic resistance
and type 2 diabetes. Our research tools
include, but are not limited to, enzymology, cloning, expression and purification
of recombinant proteins, high throughput assay development, cell biology
and computer modeling of known protein three dimensional structures for
drug design. Each of these projects relies upon key collaborations with
KU faculty as well as outside the University. |
 left to right: Andres Gonzalez, Carlos Garcia, Karla Bullon |